Circa la società

Oligovax is a biopharmaceutical company focused on developing innovative therapies for cancer. Oligovax leads molecule, Litenimod, is potent agonist of toll Like receptor 9 (TLR9), triggering both innate and adaptive immune response.

FR
Sconosciuto
Azienda non verificata